Stay updated with breaking news from Nasdaq Gnca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts at StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Genocea Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.00. The firm […]
Equities research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.35 and a current ratio […]
StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The firm has a market cap of $6,000.00, a P/E ratio of 0.00 and a beta of 1.61. The company has […]
Genocea Biosciences (NASDAQ:GNCA – Get Free Report) and Sutro Biopharma (NASDAQ:STRO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Earnings and Valuation This table compares Genocea […]
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Saturday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. […]